For More Information Contact:
Amy Rickard
Cleveland Medical Devices Inc.
Phone: 216.791.6720
arickard@clevemed.com
www.CleveMed.com
FOR IMMEDIATE RELEASE
CLEVELAND MEDICAL DEVICES INC. OBTAINS $1.2 MILLION IN NIH FUNDING FOR
EMERGENCY BRAIN MONITORING
CLEVELAND, OHIO, October 5, 2005 -
Cleveland Medical Devices Inc. (CleveMed) announced that it has been
awarded $1.2 million in National Institutes of Health SBIR Phase II Continuation funding. The proceeds from
the grant will fund the continuation and expansion of CleveMed's Emergency Brain Monitoring program.
Electroencephalography (EEG) is needed in the emergency department to improve the clinical outcome in a
large patient population, yet EEG procedures in the emergency department are almost non-existent. To date, a
crucial hurdle is the lack of EEG monitoring technology appropriate in the emergency setting. The purpose of
the program is to complete the development of the miniature, wireless EEG technology developed in the earlier
phases of the project.
"The funding will help us establish the use of EEG monitoring within the emergency department," said Aveh
Bastani, MD, emergency physician in charge of clinical research at Troy Beaumont Hospital in Troy, Michigan.
"This technology provides clinicians with otherwise unattainable information regarding the neurological status
of their most critically ill patients. Results from 70 patients showed that approximately 10% of the patients
suffered from sub-clinical seizures that would have otherwise been undetected."
According to
Hani Kayyali, CleveMed president, "We hope to pioneer the use of EEG in urgent care in the U.S.
and around the world. This extensive study will be critical in promoting the benefits of this new monitoring
capability to emergency doctors and hospital staff." Mr. Kayyali added, "This project is aligned with CleveMed's
core focus areas in developing innovative neurology and rehabilitation products that fulfill unmet clinical needs
within the clinical, research, and education markets."
About CleveMed
CleveMed was founded with the goal of developing innovative telemetry devices for a variety of medical
applications. Today, CleveMed is developing and pioneering the use of novel wireless monitoring
systems for high growth neurology and rehabilitation applications, including
movement disorders,
sleep
disorders and brain monitoring. Through these innovations, CleveMed has developed a growing range of
products that address the needs of the
medical,
research and
academic communities. For more
information, please visit
www.CleveMed.com